A thermal analysis method to predict the complete phase diagram of drug-polymer solid dispersions

International Journal of Pharmaceutics

Volumn 399, Issue 1-2, 2010, Pages 109-115

  Lin, Dexi ^a   Huang, Yanbin ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

Felodipine PAA system; Phase diagram; Phase separation; Solid dispersion; The Flory Huggins theory

Indexed keywords

FELODIPINE; POLYACRYLIC ACID;

ARTICLE; CHEMICAL INTERACTION; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; GLASS TRANSITION TEMPERATURE; PHASE SEPARATION; PRIORITY JOURNAL; THERMAL ANALYSIS;

ACRYLIC RESINS; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG CARRIERS; FELODIPINE; MODELS, CHEMICAL; PHASE TRANSITION; PREDICTIVE VALUE OF TESTS; SOLUBILITY; TRANSITION TEMPERATURE;

EID: 77956885126     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.08.013     Document Type: Article

References (30)

1. Arnauts J., Berghmans H. Amorphous thermoreversible gels of atactic polystyrene. Polym. Commun. 1987, 28:66-68.
2. Cheng S.Z.D. Phase Transitions in Polymers: The Role of Metastable States 2008, Elsevier, Amsterdam.
3. Chiou W.L., Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60:1281-1302.
4. Flory P.J. Principles of Polymer Chemistry 1953, Cornell University Press, Ithaca.
5. Friesen D.T., Shanker R., Crew M., Smithey D.T., Curatolo W.J., Nightingale J.A.S. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol. Pharm. 2008, 5:1003-1019.
6. Gashi Z., Censi R., Malaj L., Gobetto R., Mozzicafreddo M., Angeletti M., Masic A., Martino P.D. Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: a multi-methodological approach. J. Pharm. Sci. 2009, 98:4216-4228.
7. Han C.C., Bauer B.J., Clark J.C., Muroga Y., Matsushita Y., Okada M., Tran-cong Q., Chang T., Sanchez I.C. Temperature, composition and molecular-weight dependence of the binary interaction parameter of polystyrene/poly(vinyl methyl ether) blends. Polymer 1988, 29:2002-2014.
8. Janssens S., Van den Mooter G. Review: physical chemistry of solid dispersions. J. Pharm. Pharmacol. 2009, 61:1571-1586.
9. Karavas E., Ktistis G., Xenakis A., Georgarakis E. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev. Ind. Pharm. 2005, 31:473-489.
10. Koningsveld R., Stockmayer W.H., Nies E. Polymer Phase Diagrams 2001, Oxford University Press, New York.
11. Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50:47-60.
12. Marsac P.J., Shamblin S.L., Taylor L.S. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm. Res. 2006, 23:2417-2426.
13. Marsac P.J., Li T.L., Taylor L.S. Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters. Pharm. Res. 2009, 26:139-151.
14. Marsac P.J., Rumondor A.C.F., Nivens D.E., Kestur U.S., Stanciu L., Taylor L.S. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J. Pharm. Sci. 2010, 99:169-185.
15. Mohan R., Lorenz H., Myerson A.S. Solubility measurement using differential scanning calorimetry. Ind. Eng. Chem. Res. 2002, 41:4854-4862.
16. Qian F., Huang J., Hussain M.A. Drug-polymer solubility and miscibility: stability consideration and practical challenge in amorphous solid dispersion development. J. Pharm. Sci. 2010, 99:2941-2947.
17. Rubinstein M., Colby R.H. Polymer Physics 2003, Oxford University Press, New York.
18. Rumondor A.C.F., Marsac P.J., Stanford L.A., Taylor L.S. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture. Mol. Pharm. 2009, 6:1492-1505.
19. Rumondor A.C.F., Ivanisevic I., Bates S., Alonzo D.E., Taylor L.S. Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm. Res. 2009, 26:2523-2534.
20. Rumondor A.C.F., Stanford L.A., Taylor L.S. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm. Res. 2009, 26:2599-2606.
21. Serajuddin A.T.M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999, 88:1058-1066.
22. Six K., Murphy J., Weuts I., Craig D.Q.M., Verreck G., Peeters J., Brewster M., Van den Mooter G. Identification of phase separation in solid dispersions of itraconazole and Eudragit E100 using microthermal analysis. Pharm. Res. 2003, 20:135-138.
23. Strobl G. The Physics of Polymers 2007, Springer, Berlin. 3rd edition.
24. Sun Y., Tao J., Zhang G.G.Z., Yu L. Solubilities of crystalline drugs in polymers: an improved analytical method and comparison of solubilities of indomethacin and nifedipine in PVP, PVP/VA, and PVAc. J. Pharm. Sci. 2010, 99:4023-4031.
25. Tao J., Sun Y., Zhang G.G.Z., Yu L. Solubility of small-molecule crystals in polymers: d-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA. Pharm. Res. 2009, 26:855-864.
26. Vasanthavada M., Tong W.Q., Joshi Y., Kislalioglu M.S. Phase behavior of amorphous molecular dispersions II: role of hydrogen bonding in solid solubility and phase separation kinetics. Pharm. Res. 2005, 22:440-448.
27. Vasconcelos T., Sarmento B., Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov. Today 2007, 12:1068-1075.
28. Wiranidchapong C., Tucker I.G., Rades T., Kulvanich P. Miscibility and interactions between 17β-estradiol and Eudragit RS in solid dispersion. J. Pharm. Sci. 2008, 97:4879-4887.
29. Yu H.Q., Huang A.B., Xiao C.B. Characteristics of konjac glucomannan and poly(acrylic acid) blend films for controlled drug release. J. Appl. Polym. Sci. 2006, 100:1561-1570.
30. Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv. Drug Deliv. Rev. 2001, 48:27-42.